Pavan Kumar
About Pavan Kumar
Pavan Kumar serves as the Vice President and Head of Translational Medicine and Clinical Pharmacology at Nimbus Therapeutics, where he focuses on molecule and program development. With extensive experience in translational medicine, he has held leadership roles at several biotechnology companies and has a strong academic background in biotechnology and plant biology.
Current Role at Nimbus Therapeutics
Pavan Kumar serves as the Vice President and Head of Translational Medicine and Clinical Pharmacology at Nimbus Therapeutics. He has held this position since 2023, contributing to the company's focus on advancing drug development through innovative translational strategies. In this role, he leads molecule and program development, emphasizing the creation of clinical development plans tailored to specific therapeutic areas.
Previous Experience at Kronos Bio, Inc.
Before joining Nimbus Therapeutics, Pavan Kumar worked at Kronos Bio, Inc. for three years, first as Executive Director of Translational Medicine from 2020 to 2021 and then as Vice President of Translation from 2021 to 2023. During his tenure, he focused on building translational medicine capabilities and enhancing the integration of clinical data to support drug development.
Educational Background
Pavan Kumar earned a Bachelor of Technology (B.Tech) in Biotechnology from Anna University Chennai, studying from 1999 to 2003. He furthered his education at the University of California, Davis, where he obtained a Doctor of Philosophy (PhD) in Plant Biology and Virology, completing his studies from 2003 to 2008.
Expertise in Translational Medicine
Pavan Kumar specializes in building internal translational and diagnostics infrastructure. He is adept at developing and executing real-world data integrated translational and patient selection strategies within clinical settings. His expertise extends to molecular diagnostics and translation data sciences, where he employs next-generation sequencing (NGS) and liquid biopsy approaches to enhance clinical outcomes.
Career Development and Contributions
Throughout his career, Pavan Kumar has held various positions that contributed to his expertise in translational medicine. He worked as a Senior Scientist and Scientist at Eisai from 2010 to 2015, and as an Executive Director of Translational Sciences at Twentyeight-Seven Therapeutics from 2019 to 2020. His roles have involved interfacing across internal and external functions to enhance translational medicine and developing partnerships for biomarker discovery and clinical validation.